Previous 10 | Next 10 |
R1 RCM press release ( NASDAQ: RCM ): Q3 GAAP EPS of -$0.07 misses by $0.19 . Revenue of $496M (+30.6% Y/Y) misses by $27.69M . For 2022, R1 now expects to generate:-Revenue of between $1,790 million and $1,800 milliovs $1.87B Consensus GAAP operating...
MURRAY, Utah, Nov. 08, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2022. ...
Lee Rivas Appointed Chief Executive Officer, effective January 1, 2023; Joseph Flanagan to Continue Serving on Board John Sparby, Chief Operating Officer, Appointed President MURRAY, Utah, Nov. 08, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or t...
R1 RCM ( NASDAQ: RCM ) is scheduled to announce Q3 earnings results on Tuesday, November 8th, before market open. The consensus EPS Estimate is $0.14 and the consensus Revenue Estimate is $523.69M (+37.9% Y/Y). Over the last 1 year, RCM has beaten EPS estimates 25%...
R1 RCM Inc. ( NASDAQ: RCM ), a provider of revenue cycle management services to healthcare companies, dropped for the third straight session on Friday to reach a 52-week low on below-average volume. About ~1.4M RCM shares have changed hands, compared to the 65-day average volu...
MURRAY, Utah, Oct. 19, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ...
MURRAY, Utah, Sept. 29, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), today released two comprehensive reports that explore financial challenges facing the healthcare industry and novel ways executives are overcoming them through revenue cycle management (RCM) par...
R1 RCM ( NASDAQ: RCM ) stock slid 7.2% postmarket on Thursday after the firm announced an underwritten public offering of 15M shares by selling stockholder TCP-ASC ACHI Series. The stockholder is a Delaware series limited liability limited partnership owned by Ascension He...
MURRAY, Utah, Sept. 08, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1”) (NASDAQ: RCM) today announced the commencement of an underwritten public offering of 15,000,000 shares of its common stock by TCP-ASC ACHI Series LLLP (“TCP-ASC”), a Delaware series limited liabi...
MURRAY, Utah, Aug. 31, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the Baird 2022 Global Hea...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A ...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...